Clinical trials
Abdominal Pain trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
70 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 5 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 4 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 6 |
| 2024 | 5 |
| 2025 | 7 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 45 |
| Recruiting | 9 |
| Not yet recruiting | 6 |
| Unknown status | 4 |
| Terminated | 3 |
| Withdrawn | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Baylor College of Medicine | 4 |
| Stanford University | 4 |
| University of Michigan | 3 |
| Beth Israel Deaconess Medical Center | 2 |
| Cedars-Sinai Medical Center | 2 |
| Johns Hopkins University | 2 |
| Radicle Science | 2 |
| Seattle Children's Hospital | 2 |
| Supplement Formulators, Inc. | 2 |
| University of California, Los Angeles | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abdominal Pain | 70 |
| Irritable Bowel Syndrome | 22 |
| Diarrhea | 9 |
| Chronic Pain | 6 |
| Constipation | 6 |
| Digestive System Diseases | 6 |
| Gastrointestinal Diseases | 6 |
| Nausea | 6 |
| Pancreatitis, Chronic | 6 |
| Gastroesophageal Reflux | 5 |
Trials
Showing 1 to 25 of 70. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.